Results 11 to 20 of about 2,011 (197)

Increased Choroidal Thickness in Morquio Syndrome [PDF]

open access: goldCase Reports in Ophthalmology, 2021
The purpose of this clinical case report is to describe a case of mucopolysaccharidosis type IVA (MPS IVA), or Morquio syndrome, with increased choroidal thickness in enhanced-depth imaging optical coherence tomography (EDI-OCT) which can represent ...
Augusto Magalhães   +6 more
doaj   +4 more sources

Expanding the Spectrum: A Rare Case of Morquio Syndrome With Bronchial Asthma and Seizure Disorder [PDF]

open access: yesClinical Case Reports
This case highlights a rare co‐existence of Morquio syndrome with bronchial asthma and myoclonic seizures, expanding the known clinical spectrum. It emphasizes the need for comprehensive, multidisciplinary management to address multisystem involvement ...
Bijay Bastola   +4 more
doaj   +3 more sources

Orthopedic management of the extremities in patients with Morquio A syndrome

open access: goldJournal of Children's Orthopaedics, 2014
Background Musculoskeletal involvement in Morquio A syndrome (mucopolysaccharidosis IVA; MPS IVA) contributes significantly to morbidity and mortality. While the spinal manifestations of the disorder have received considerable attention in the literature,
Klane K White   +2 more
exaly   +3 more sources

RNA analysis of the GALNS transcript reveals novel pathogenic mechanisms associated with Morquio syndrome A [PDF]

open access: yesMolecular Genetics and Metabolism Reports, 2022
Morquio syndrome A (Mucopolysaccharidosis IVA, MPS IVA) is an autosomal recessive lysosomal storage disorder caused by deficiency of N-acetyl-galactosamine-6-sulfatase (GALNS) which catabolizes the glycosaminoglycans (GAG), keratan sulfate and ...
Young Bae Sohn   +10 more
doaj   +2 more sources

Automated Assessment of Thoracic-Abdominal Asynchrony in Patients with Morquio Syndrome [PDF]

open access: yesDiagnostics, 2021
Morquio syndrome is a rare disease caused by a disorder in the storage of mucopolysaccharides that affects multiple organs, including musculoskeletal, respiratory, cardiovascular, and digestive systems. Respiratory failure is one of the leading causes of
Madhavi V. Ratnagiri   +5 more
doaj   +2 more sources

A second reported malignancy in a patient with Morquio syndrome [PDF]

open access: yesAutopsy and Case Reports, 2017
Morquio syndrome is a rare lysosomal storage disease that affects multiple organ systems. However, it is rarely associated with malignancy. We present the case of a 30-year old man with Morquio syndrome associated with gastric adenocarcinoma.
Ameer Hamza   +5 more
doaj   +2 more sources

Understanding bias when estimating life expectancy from age at death: a simulation approach applied to Morquio syndrome A [PDF]

open access: yesBMC Research Notes, 2022
Objective Life expectancy can be estimated accurately from a cohort of individuals born in the same year and followed from birth to death. However, due to the resource-consuming nature of following a cohort prospectively, life expectancy is often ...
Xue Yin, Jaeil Ahn, Simina M. Boca
doaj   +2 more sources

General anaesthesia in an adult patient with Morquio syndrome with emphasis on airway issues

open access: diamondBiomolecules & Biomedicine, 2012
Patients with Morquio syndrome possess a number of characteristics which may complicate an anaesthetic procedure. The most important is that a deposition of mucopolysaccharides in the soft tissues of the oro-pharynx distorts the airway, making the airway
Lajla Kadić, Jacques J. Driessen
doaj   +3 more sources

Morquio syndrome: A radiological diagnosis

open access: diamondCHRISMED Journal of Health and Research, 2015
Mucopolysaccharidoses (MPS) are a family of inherited metabolic diseases that results from the deficiency of lysosomal enzymes involved in the degradation of the glycosaminoglycans (MPS).
Sadhanandham Shrinuvasan   +1 more
doaj   +2 more sources

Mortality in patients with morquio syndrome a. [PDF]

open access: yesJIMD Rep, 2015
Morquio syndrome A (mucopolysaccharidosis type IVA) is an autosomal recessive, life-limiting lysosomal storage disease characterized by deficient activity of the enzyme galactosamine-6-sulfatase. The disease affects multiple body systems, and patients require multidisciplinary care from an early age.To better understand the natural progression of the ...
Lavery C, Hendriksz C.
europepmc   +4 more sources

Home - About - Disclaimer - Privacy